Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-05-15, Stock:LLY, The news for the past five days is as follows:
2019-05-08: NEWS1: TV pitches for prescription drugs will have to include price.NEWS2: Drugmakers will have to reveal medication prices in TV ads.NEWS3: APNewsBreak: Drugmakers will have to reveal prices in TV ads.NEWS4: AAN 2019: Two New Analyses of Lasmiditan Phase 3 Studies Measured Onset of Effect and the Effect of Lasmiditan in Patients with Prior Triptan Experience.
2019-05-09: NEWS1: Radius (RDUS) Posts Narrower Q1 Loss, Misses on Revenues.NEWS2: Radius (RDUS) Posts Narrower Q1 Loss, Misses on Revenues.NEWS3: Radius (RDUS) Posts Narrower Q1 Loss, Misses on Revenues.NEWS4: Why this former health care CEO thinks this Uber board member is crucial to its success.
2019-05-10: NEWS1: Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions.
2019-05-13: NEWS1: Lilly's CYRAMZA® (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinoma.
2019-05-14: NEWS1: Top Research Reports for Alphabet, Eli Lilly & CVS Health.NEWS2: Top Research Reports for Alphabet, Eli Lilly & CVS Health.NEWS3: Top Research Reports for Alphabet, Eli Lilly & CVS Health.NEWS4: Lilly's Cyramza Gets FDA Nod for Second-Line Liver Cancer.NEWS5: Lilly's Cyramza Gets FDA Nod for Second-Line Liver Cancer.NEWS6: Lilly's Cyramza Gets FDA Nod for Second-Line Liver Cancer.

Answer: Rise